Patent US5384239A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5384239A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for analyzing the glycation of hemoglobin

Assignee: Chronomed Inc
•
Filing: 1993-01-21
•
Granted: 1995-01-24
•
Expires: 2013-01-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract As red blood cells age, their hemoglobin is progressively glycosylated. This invention relates to analyzing the history of blood sugar metabolism over a period of several months by taking a blood sample, separating the cells into age-ordered cohorts, determining glycohemoglobin levels in the cells of each cohort, and correlating glycohemoglobin levels with red blood cell age, while correcting for the reversibility of the Amadori rearrangement.

Inventors

  • 👤 Alexander Saunders

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 06:40
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/66; G01N33/72; G01N33/721; G01N33/723

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 196 words
A method of determining an individual history of blood sugar control which comprises: (a) taking a sample of red blood cells from the individual, wherein over the life of the red blood cells hemoglobin has been glycosylated to form a glycohemolobin, said reaction being an Amadori rearrangement, which is slowly reversible; (b) separating the red blood cells according to age into a plurality of cohorts, and determining the average age of the red blood cells in each cohort, the average age differing from cohort-to-cohort; (c) measuring the average glycohemoglobin levels of said red blood cells on a cohort-by-cohort basis, and correlating said average glycohemoglobin level with said average age for each cohort, while correcting for the reversibility of the Amadori rearrangement, so as to obtain a history of the individual's blood sugar levels over the lifespan of said red blood cells; and (d) examining said history for trends indicative of changes in blood sugar control; wherein the correction is made by applying a transform of the form ##EQU2## where y is the untransformed mean glycohemoglobin level for the cohort, a and b are constants, e is the base of the natural logarithm and t is time.
Claim 2
Independent Claim 196 words
A method of determining an individual history of blood sugar control which comprises: (a) taking a sample of red blood cells from the individual, wherein over the life of the red blood cells hemoglobin has been glycosylated to form a glycohemolobin, said reaction being an Amadori rearrangement, which is slowly reversible; (b) separating the red blood cells according to age into a plurality of cohorts, and determining the average age of the red blood cells in each cohort, the average age differing from cohort-to-cohort; (c) measuring the average glycohemoglobin levels of said red blood cells on a cohort-by-cohort basis, and correlating said average glycohemoglobin level with said average age for each cohort, while correcting for the reversibility of the Amadori rearrangement, so as to obtain a history of the individual's blood sugar levels over the lifespan of said red blood cells; and (d) examining said history for trends indicative of changes in blood sugar control; wherein the correction is made by applying a transform of the form ##EQU2## where y is the untransformed mean glycohemoglobin level for the cohort, a and b are constants, e is the base of the natural logarithm and t is time.
Claim 3
Dependent Claim 17 words
The method of claim 1 wherein the sample is separated into between 8 and 20 age cohorts.
Claim 4
Dependent Claim 16 words
The method of claim 1 wherein the mean pyruvate kinase level is determined for each cohort.
Claim 5
Dependent Claim 50 words
The method of claim 1 wherein the Amadori rearrangement results in the formation of an adduct of hemoglobin with a sugar selected from the group consisting of fructosamine, 5-deoxy-xylulose-1-phosphate, galactulose and fructose-6-phosphate and the level of said adduct in the sampled red blood cells is determined on a cohort-by-cohort basis.

References Cited (Backward Citations)

US4835097A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-01-23 1998-07-25 1999-01-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-01-23 2002-07-25 2003-01-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-01-23 2006-07-25 2007-01-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag